Head-to-head · Value Score
CoreAge Rx vs BiltRx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, BiltRx a 79. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameBiltRx
#68 · Grade B · Fair Price
Est. first month
$81/mo (compounded)
Save ~94% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 79 — an est. $99/mo first month, with no teaser step-up baked in. BiltRx isn't out of it: Someone who wants the compounded and brand-name prices side by side, with the regulatory difference stated plainly.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | BiltRx |
|---|---|---|
| Value Score | 93 (A+) | 79 (B) |
| Est. first month | $99/mo | $81/mo (compounded) |
| Save vs brand-name | ~89% | ~94% |
| Semaglutide | $99/mo | $81/mo (compounded) |
| Tirzepatide | $149/mo | $129/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
BiltRx
BiltRx sells compounded semaglutide at $81 and tirzepatide at $129 a month beside brand-name Mounjaro and Wegovy, labeling each product FDA approved or not on the storefront itself.
Why it's a deal
- Marks every product FDA APPROVED or NOT FDA APPROVED on the storefront next to the price, which is the disclosure most sellers bury in a footnote
- Among the lowest published rates tracked here — $81 semaglutide and $129 tirzepatide
- Carries brand-name Mounjaro and Wegovy alongside the compounded products and prices them openly at $1,499 and $1,849
- States that medications are prescription-only and compounded by fully licensed US 503A pharmacies using FDA-approved or USP-grade ingredients
The fine print
- The covered states sit behind a check-availability gate rather than being listed
- Starting prices may rise depending on the plan and dose chosen
- The 503A pharmacies are described by category but never named
- GLP-1s sit inside a broad health-optimization platform covering men's health, women's health and aesthetics
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to BiltRx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.